| COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) L Pagano, J Salmanton-García, F Marchesi, A Busca, P Corradini, ... Journal of hematology & oncology 14 (1), 168, 2021 | 255 | 2021 |
| Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells GJ Schuurhuis, MH Meel, F Wouters, LA Min, M Terwijn, NA de Jonge, ... PloS one 8 (11), e78897, 2013 | 69 | 2013 |
| Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey L Pagano, J Salmanton-García, F Marchesi, O Blennow, ... Blood, The Journal of the American Society of Hematology 140 (26), 2773-2787, 2022 | 65 | 2022 |
| Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: an EPICOVIDEHA survey report O Blennow, J Salmanton‐García, P Nowak, F Itri, J Van Doesum, ... American journal of hematology 97 (8), E312-E317, 2022 | 51 | 2022 |
| DNA METHYLATION INHIBITORS INDUCE TELOMERE DYSFUNCTION AND APOPTOSIS IN HUMAN LEUKEMIA CELLS THAT IS ATTENUATED BY OVER-EXPRESSION OF TELOMERASE REVERSE TRANSCRIPTASE (TERT) D Xu, N de Jonge, X Zhang, B Li, M Bjorkholm HAEMATOLOGICA 99, 555-555, 2014 | 39* | 2014 |
| Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study M Hoenigl, J Salmanton-García, M Egger, JP Gangneux, T Bicanic, ... The Lancet Infectious Diseases 23 (6), 751-761, 2023 | 38 | 2023 |
| Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: a systematic review and expert consensus recommendation from the … J Stemler, N de Jonge, N Skoetz, J Sinkó, RJ Brüggemann, R Ben-Ami, ... The Lancet Haematology 9 (5), e361-e373, 2022 | 35 | 2022 |
| The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole‐resistance. A nationwide survey and rationale … AFAD Schauwvlieghe, N De Jonge, K Van Dijk, PE Verweij, ... Mycoses 61 (9), 656-664, 2018 | 30 | 2018 |
| Improved clinical outcome of COVID‐19 in hematologic malignancy patients receiving a fourth dose of anti‐SARS‐CoV‐2 vaccine: an EPICOVIDEHA report J Salmanton‐García, F Marchesi, A Glenthøj, YM Bilgin, J Van Praet, ... Hemasphere 6 (11), e789, 2022 | 27 | 2022 |
| Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised … NA de Jonge, JJ Sikkens, S Zweegman, A Beeker, P Ypma, AH Herbers, ... The Lancet Haematology 9 (8), e563-e572, 2022 | 23 | 2022 |
| COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA) F Marchesi, J Salmanton-García, Z Emarah, K Piukovics, M Nucci, ... Haematologica 108 (1), 22, 2023 | 22 | 2023 |
| Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry A Busca, J Salmanton-García, F Marchesi, F Farina, GC Seval, ... Frontiers in immunology 14, 1125030, 2023 | 19 | 2023 |
| Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry J Salmanton-García, F Marchesi, MG da Silva, F Farina, J Dávila-Valls, ... EClinicalMedicine 58, 2023 | 17 | 2023 |
| The impact of the updated EORTC/MSG criteria on the classification of hematological patients with suspected invasive pulmonary aspergillosis H Lamberink, A Wagemakers, KCE Sigaloff, R van Houdt, NA de Jonge, ... Clinical Microbiology and Infection 28 (8), 1120-1125, 2022 | 14 | 2022 |
| Clinical Impact of Polymerase Chain Reaction–Based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study S Huygens, A Dunbar, JB Buil, CHW Klaassen, PE Verweij, K van Dijk, ... Clinical Infectious Diseases 77 (1), 38-45, 2023 | 11 | 2023 |
| B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA) MS Infante, J Salmanton-García, A Fernandez-Cruz, F Marchesi, O Jaksic, ... Frontiers in oncology 12, 992137, 2022 | 10 | 2022 |
| Clinical impact of PCR-based Aspergillus and azole resistance detection in invasive aspergillosis. A prospective multicenter study. S Huygens, A Dunbar, JB Buil, CHW Klaassen, PE Verweij, K van Dijk, ... Clinical Infectious Diseases: an Official Publication of the Infectious …, 2023 | 9 | 2023 |
| Indwelling time of peripherally inserted central catheters and incidence of bloodstream infections in haematology patients: a cohort study MG Caris, NA de Jonge, HJ Punt, DM Salet, VMT de Jong, ... Antimicrobial Resistance & Infection Control 11 (1), 37, 2022 | 8 | 2022 |
| Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings G Rossi, J Salmanton-García, C Cattaneo, F Marchesi, J Dávila-Valls, ... International Journal of Infectious Diseases 137, 98-110, 2023 | 7 | 2023 |
| Guidance of empirical antimicrobial therapy by surveillance cultures in high-risk neutropenic patients: a retrospective cohort study JR de la Court, J Heijmans, J Huynh, E Sieswerda, NA de Jonge, ... Antimicrobial Resistance & Infection Control 11 (1), 160, 2022 | 5 | 2022 |
Jeroen Janssenassistant-professor, Dept of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Centers, location VUmc, Amsterdam, The NetherlandsVerified email at amsterdamumc.nl
